Bhubaneswar, December 12 (LocalWire): The state government has ordered a probe into the alleged use of substandard and spurious drugs at Puri District Headquarters hospital that triggered adverse drug reaction among the inpatients.
The entire stock of the suspected spurious drug, Ceftriaxone, an antibiotic to treat bacterial infections has been withdrawn and has sent to the State Drugs Control Laboratory for its potency test.
“The batch of Ceftriaxone drug was centrally procured from the government-run Odisha State Medical Corporation,” Puri district medical officer Nilakantha Mishra told the LocalWire.
Around 100 inpatients, mostly in the surgery wards, were reported to have experienced adverse drug reactions immediately after the particular brand of antibiotics was administered to them on Wednesday.
“The affected inpatients experienced dizziness and had begun vomiting. Another drug was immediately administered to them to get the better of the suspected drug reaction,” he said.
The health official refused to divulge further details saying that the ongoing inquiry will ascertain whether the centrally procured antibiotic was spurious or not.
An official in the State Drugs Control unit in Bhubaneswar said that the particular brand of antibiotics might have been passed through certification in a testing laboratory outside Odisha.